Safety and efficacy have not been established in children and adolescents under 18 years

When to seek medical help: Call 999 immediately if dizziness is accompanied by signs of stroke (facial drooping, arm weakness, speech difficulties), severe chest pain, severe shortness of breath, or collapse Contact your GP urgently or call NHS 111 if: Dizziness is severe, persistent, or worsening You experience fainting or near-fainting episodes Dizziness is accompanied by palpitations or visual disturbances You have recurrent episodes that interfere with daily activities You suspect hypoglycaemia but symptoms do not resolve with carbohydrate intake Your clinician may recommend: Temporarily reducing the dose or pausing treatment Reviewing concurrent medications that may contribute to dizziness Investigating underlying causes through blood pressure monitoring, ECG, or blood tests Adjusting the rate of dose escalation Switching to an alternative weight management strategy if symptoms persist Do not stop your medication without medical advice unless you suspect a severe reaction, in which case stop and seek urgent medical help

Your doctor can help you find the safest, most effective treatment and support you in achieving your best quality of life
GHK-Cu 100mg Strength: 100 mg CAS: 49557-75-7 Chemical Formula: CHNOCu Molecular weight: 401.91 g/mol Peptide Sequence: Gly-His-Lys(Cu2+) Synonyms: Copper peptide, GHK, Tripeptide, ghkcu, GHK-Cu acetate, Gly-His-Lys-Cu(II) Storage: Store 28 C (20 C long-term)